Nuzenio

Semaglutide Trial

Semaglutide Trial news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Veru Reports Q3 FY2026: Net Loss $7.0M, Cash $23.9M; PLATEAU Trial Fully Enrolled - TradingViewTradingView · Mon, 10 Aug 2026 11:03:01 GMTCU Anschutz clinical trial finds GLP-1s help curb alcohol use disorder - 9News9News · Mon, 10 Aug 2026 03:56:00 GMTCU Anschutz trial finds semaglutide pills curb alcohol use disorder - 9News9News · Mon, 10 Aug 2026 03:30:00 GMTLilly's Oral GLP-1 Foundayo Outperforms Oral Semaglutide in Phase 3 Type 2 Diabetes Trial - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 19:52:06 GMTSemaglutide Showed Promise in MASH Fibrosis Trial - EMJEMJ · Fri, 07 Aug 2026 09:02:12 GMTVivani Medical Completes Dosing in Phase 1 Trial of Semaglutide Implant - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:39:00 GMTVeterans affairs announces trial of GLP-1 treatment for alcohol use disorder - FOX Carolina NewsFOX Carolina News · Wed, 05 Aug 2026 22:30:00 GMTVA Begins Enrolling 600 Veterans in Trial Testing Whether Semaglutide Reduces Alcohol Use - Medical DailyMedical Daily · Tue, 04 Aug 2026 14:15:13 GMT

Timeline

Mon, 10 Aug 2026 11:03:01 GMTVeru Reports Q3 FY2026: Net Loss $7.0M, Cash $23.9M; PLATEAU Trial Fully Enrolled - TradingView
Mon, 10 Aug 2026 03:56:00 GMTCU Anschutz clinical trial finds GLP-1s help curb alcohol use disorder - 9News
Mon, 10 Aug 2026 03:30:00 GMTCU Anschutz trial finds semaglutide pills curb alcohol use disorder - 9News
Fri, 07 Aug 2026 19:52:06 GMTLilly's Oral GLP-1 Foundayo Outperforms Oral Semaglutide in Phase 3 Type 2 Diabetes Trial - BioPharm International
Fri, 07 Aug 2026 09:02:12 GMTSemaglutide Showed Promise in MASH Fibrosis Trial - EMJ
Fri, 07 Aug 2026 06:39:00 GMTVivani Medical Completes Dosing in Phase 1 Trial of Semaglutide Implant - The Clinical Trial Vanguard

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Semaglutide Trial.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.